Harry and Jeanette Weinberg Foundation

Recent papers from Harry and Jeanette Weinberg Foundation

1. Radiotherapy, lymphopenia and improving the outcome for glioblastoma: a narrative reviewChinese Clinical Oncology · 2023
2. Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrenceThe Medicine Forum · 2021
3. Small molecule immunomodulation: the tumor microenvironment and overcoming immune escapeJournal for ImmunoTherapy of Cancer · 2019
4. Double‐blind, randomized phase 3 trial of low‐dose 13‐cis retinoic acid in the prevention of second primaries in head and neck cancer: Long‐term follow‐up of a trial of the Eastern Cooperative Oncology Group‐ACRIN Cancer Research Group (C0590)Cancer · 2017
5. Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30JNCI Journal of the National Cancer Institute · 2017
6. Angiosarcoma Arising in a Patient with a 10-Year-Old HemangiomaCase Reports in Oncological Medicine · 2014
7. Clonal dominance of CD133+ subset population as risk factor in tumor progression and disease recurrence of human cutaneous melanomaInternational Journal of Oncology · 2012
8. Peripheral Pulmonary Nodules and Electromagnetic Navigational BronchoscopyJournal of Bronchology & Interventional Pulmonology · 2012
9. Molecular Diagnostics in Urologic Malignancies: A Work in ProgressArchives of Pathology & Laboratory Medicine · 2011
10. Molecular diagnostics in urologic malignancies: a work in progress.Archives of Pathology & Laboratory Medicine · 2011
11. Maintenance Therapy for Ovarian Cancer: Of Helsinki and HippocratesJournal of Clinical Oncology · 2009
12. Filamin A Modulates Kinase Activation and Intracellular Trafficking of Epidermal Growth Factor Receptors in Human Melanoma CellsEndocrinology · 2009
13. CA‐125 change after chemotherapy in prediction of treatment outcome among advanced mucinous and clear cell epithelial ovarian cancersCancer · 2009
14. The prognostic value of pretreatment CA 125 in patients with advanced ovarian carcinomaCancer · 2009
15. The Immune Adjuvant Properties of Front-line Carboplatin-Paclitaxel: A Randomized Phase 2 Study of Alternative Schedules of Intravenous Oregovomab Chemoimmunotherapy in Advanced Ovarian CancerJournal of Immunotherapy · 2008